Sermorelin
Growth-hormone axis (GHRH analogue)
At a glance
Indications & what it's studied for
Historically a diagnostic/therapeutic GH agent; now used in anti-aging/wellness clinics to raise GH/IGF-1 for body composition, recovery, and sleep.
Contraindications & cautions
Active cancer; pituitary disease; pregnancy; hypersensitivity. Caution with hypothyroidism (treat first) and glucose intolerance.
Commonly reported dosing
Commonly reported as a small nightly subcutaneous dose to mimic the natural GH pulse; reconstituted and refrigerated.
Routes of administration
Subcutaneous injection, usually at night.
Don't combine with
Somatostatin, glucocorticoids, and antithyroid agents blunt the response.
Reported to stack with
Frequently combined with a GHRP/secretagogue (ipamorelin) for a synergistic GH pulse — a popular but not safety-validated pairing.
Note: "stacking" combines multiple agents and multiplies unknowns; popularity of a combination is not evidence of its safety.
What the research actually shows
Older clinical work on GH secretion and growth; modern wellness use rests largely on mechanism and anecdote rather than long-term trials.
Before acting on anything here, see Safety & the grey market and how to read a COA.